Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study

NCT03478020 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aquinox Pharmaceuticals (Canada) Inc.